Cargando…
Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction
Neuropeptides induce signal transduction across the plasma membrane by acting through cell-surface receptors. The dynorphins, endogenous ligands for opioid receptors, are an exception; they also produce non-receptor-mediated effects causing pain and neurodegeneration. To understand non-receptor mech...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385918/ https://www.ncbi.nlm.nih.gov/pubmed/25766322 http://dx.doi.org/10.1038/cddis.2015.39 |
_version_ | 1782365106358714368 |
---|---|
author | Maximyuk, O Khmyz, V Lindskog, C-J Vukojević, V Ivanova, T Bazov, I Hauser, K F Bakalkin, G Krishtal, O |
author_facet | Maximyuk, O Khmyz, V Lindskog, C-J Vukojević, V Ivanova, T Bazov, I Hauser, K F Bakalkin, G Krishtal, O |
author_sort | Maximyuk, O |
collection | PubMed |
description | Neuropeptides induce signal transduction across the plasma membrane by acting through cell-surface receptors. The dynorphins, endogenous ligands for opioid receptors, are an exception; they also produce non-receptor-mediated effects causing pain and neurodegeneration. To understand non-receptor mechanism(s), we examined interactions of dynorphins with plasma membrane. Using fluorescence correlation spectroscopy and patch-clamp electrophysiology, we demonstrate that dynorphins accumulate in the membrane and induce a continuum of transient increases in ionic conductance. This phenomenon is consistent with stochastic formation of giant (~2.7 nm estimated diameter) unstructured non-ion-selective membrane pores. The potency of dynorphins to porate the plasma membrane correlates with their pathogenic effects in cellular and animal models. Membrane poration by dynorphins may represent a mechanism of pathological signal transduction. Persistent neuronal excitation by this mechanism may lead to profound neuropathological alterations, including neurodegeneration and cell death. |
format | Online Article Text |
id | pubmed-4385918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43859182015-04-07 Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction Maximyuk, O Khmyz, V Lindskog, C-J Vukojević, V Ivanova, T Bazov, I Hauser, K F Bakalkin, G Krishtal, O Cell Death Dis Original Article Neuropeptides induce signal transduction across the plasma membrane by acting through cell-surface receptors. The dynorphins, endogenous ligands for opioid receptors, are an exception; they also produce non-receptor-mediated effects causing pain and neurodegeneration. To understand non-receptor mechanism(s), we examined interactions of dynorphins with plasma membrane. Using fluorescence correlation spectroscopy and patch-clamp electrophysiology, we demonstrate that dynorphins accumulate in the membrane and induce a continuum of transient increases in ionic conductance. This phenomenon is consistent with stochastic formation of giant (~2.7 nm estimated diameter) unstructured non-ion-selective membrane pores. The potency of dynorphins to porate the plasma membrane correlates with their pathogenic effects in cellular and animal models. Membrane poration by dynorphins may represent a mechanism of pathological signal transduction. Persistent neuronal excitation by this mechanism may lead to profound neuropathological alterations, including neurodegeneration and cell death. Nature Publishing Group 2015-03 2015-03-12 /pmc/articles/PMC4385918/ /pubmed/25766322 http://dx.doi.org/10.1038/cddis.2015.39 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International Licence. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons licence, users will need to obtain permission from the licence holder to reproduce the material. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0 |
spellingShingle | Original Article Maximyuk, O Khmyz, V Lindskog, C-J Vukojević, V Ivanova, T Bazov, I Hauser, K F Bakalkin, G Krishtal, O Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title | Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title_full | Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title_fullStr | Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title_full_unstemmed | Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title_short | Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
title_sort | plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385918/ https://www.ncbi.nlm.nih.gov/pubmed/25766322 http://dx.doi.org/10.1038/cddis.2015.39 |
work_keys_str_mv | AT maximyuko plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT khmyzv plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT lindskogcj plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT vukojevicv plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT ivanovat plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT bazovi plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT hauserkf plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT bakalking plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction AT krishtalo plasmamembraneporationbyopioidneuropeptidesapossiblemechanismofpathologicalsignaltransduction |